Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 23644674)

Published in J Cancer Res Clin Oncol on May 04, 2013

Authors

Y Dittmar1, A Altendorf-Hofmann, S Schüle, M Ardelt, O Dirsch, I B Runnebaum, U Settmacher

Author Affiliations

1: Department of General, Visceral und Vascular Surgery, Jena University Hospital, Erlanger Allee 101, 07747 Jena, Germany. yves.dittmar@med.uni-jena.de

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol (2008) 3.07

Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49

Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg (2008) 2.14

An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg (2003) 1.71

Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol (2007) 1.66

Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol (2005) 1.59

Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol (2004) 1.45

HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis. Breast Cancer Res Treat (2011) 1.29

Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer (2011) 1.21

The role of surgery in metastatic breast cancer. Eur J Cancer (2011) 1.13

ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer. Breast Cancer Res Treat (2011) 1.12

Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol (2000) 1.12

Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol (2009) 1.12

Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg (2005) 1.08

A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist (2003) 1.06

Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol (2007) 1.03

The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg (2006) 0.96

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat (2005) 0.95

Liver metastases from breast cancer. Results of surgical resection. Hepatogastroenterology (2002) 0.95

Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol (2010) 0.94

Liver resection for metastases from breast cancer. J Surg Oncol (2008) 0.94

Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis (2011) 0.93

Liver metastases of breast cancer: results of liver resection. Anticancer Res (1998) 0.89

Resection of colorectal liver metastases. J Gastrointest Surg (2011) 0.88

Targeted therapy in breast cancer: what's new? Swiss Med Wkly (2011) 0.86

Personalized therapy in breast cancer. Onkologie (2012) 0.83

Multi-modality treatment of colorectal liver metastases. World J Gastroenterol (2012) 0.82

Surgery for liver metastases from breast cancer. HPB (Oxford) (2006) 0.81

Surgical treatment of liver metastases from breast cancer. Minerva Chir (2004) 0.80

Radiofrequency ablation in the treatment of breast cancer liver metastases. Clin Oncol (R Coll Radiol) (2010) 0.78

Articles by these authors

(truncated to the top 100)

Resection of colorectal liver metastases. World J Surg (1995) 7.73

Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36

Factors influencing the natural history of colorectal liver metastases. Lancet (1994) 3.61

Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24

p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59

Correlation of polypoid lesions in the distal colorectum and proximal colon in asymptomatic screening subjects. Eur J Gastroenterol Hepatol (1996) 1.45

p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45

Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization:: histological and clinical findings in 7,621 patients. Catheter Cardiovasc Interv (2000) 1.45

[Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg (2001) 1.44

Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver. Endoscopy (1997) 1.42

Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment option. BJOG (2013) 1.42

[Operation technique determines frequency of recurrence of colorectal carcinoma]. Chirurg (1999) 1.40

[Mesenteric artery occlusion as a rare complication of thromboangiitis obliterans]. Chirurg (2002) 1.38

Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38

[Colonic stenting: an opportunity with a risk : A critical evaluation]. Chirurg (2015) 1.38

Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37

Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis (2004) 1.33

Randomized controlled multicenter international clinical trial of self-gripping Parietex™ ProGrip™ polyester mesh versus lightweight polypropylene mesh in open inguinal hernia repair: interim results at 3 months. Hernia (2012) 1.32

Prognosis of gastric carcinoid tumours. Digestion (1995) 1.23

Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis (1997) 1.21

Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol (1998) 1.21

Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys (1990) 1.17

Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy (1997) 1.14

p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res (1998) 1.13

Resection of colorectal liver metastases. Langenbecks Arch Surg (1999) 1.13

18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant (2009) 1.12

Resection of colorectal liver metastases revisited. J Gastrointest Surg (2006) 1.10

Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. Transplant Proc (1999) 1.09

CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther (2003) 1.09

[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol (2011) 1.07

[Organ-preserving therapy in invasive bladder carcinoma]. Dtsch Med Wochenschr (1992) 1.06

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer (2000) 1.04

Balloon-protected carotid artery stenting: relationship of periprocedural neurological complications with the size of particulate debris. Circulation (2001) 1.04

Noninvasive analysis of conjunctival microcirculation during carotid artery surgery reveals microvascular evidence of collateral compensation and stenosis-dependent adaptation. J Vasc Surg (2003) 1.03

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer (1999) 1.03

Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg (1998) 1.03

Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. Cell Death Dis (2013) 1.01

Surgical management of multiple bilateral fibroadenoma of the breast: the Ribeiro technique modified by Rezai. Anticancer Res (2009) 1.00

Survival after liver transplantation for hepatocellular carcinoma in cirrhosis according to the underlying liver disease. Transplant Proc (2001) 0.99

Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys (1999) 0.98

A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis (2005) 0.98

Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. Anticancer Res (1998) 0.97

[Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions]. Swiss Surg (1996) 0.96

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study. Ann Oncol (2012) 0.95

Polycystic liver grafts for orthotopic liver transplantation. Transplant Proc (2000) 0.95

Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther (2001) 0.94

Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys (1994) 0.94

p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells. Oncology (1999) 0.94

[The certification of advanced therapy medicinal products. A quality label for product development in small and medium-sized enterprises]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.94

Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin. Int J Cancer (1998) 0.93

Tumor implantation from needle biopsy of hepatic metastases. Hepatogastroenterology (1990) 0.92

Adherent appendix vermiformis within an incisional hernia after kidney transplantation mimicking acute appendicitis: report of a case. Hernia (2010) 0.92

Liver transplantation for treatment of intrahepatic Osler's disease: first experiences. Transplantation (2001) 0.92

Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res (2000) 0.91

Rapid progression of bacterial aortitis to an ascending aortic mycotic aneurysm documented by transesophageal echocardiography. J Am Soc Echocardiogr (2001) 0.91

Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography. Gene Ther (2002) 0.91

Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation (2001) 0.90

Insulin-like growth factor I and truncated keratinocyte growth factor accelerate healing of left-sided colonic anastomoses. Br J Surg (2001) 0.90

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer (2005) 0.88

Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol (2001) 0.87

Laparoscopic resection of perforated Meckel's diverticulum in a patient with clinical symptoms of acute appendicitis. Surg Endosc (2002) 0.87

Transgastral retroperitoneal endoscopy in septic patients with pancreatic necrosis or infected pancreatic pseudocysts. Z Gastroenterol (2008) 0.86

Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines. Gynecol Oncol (1993) 0.86

Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up. Int Immunopharmacol (2005) 0.86

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma. J Cancer Res Clin Oncol (2011) 0.86

Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes. J Natl Cancer Inst (2001) 0.86

Hepatic arterial perfusion is essential for the spontaneous recovery from focal hepatic venous outflow obstruction in rats. Am J Transplant (2011) 0.86

[Spontaneous splenic rupture in metastatic malignant melanoma]. Zentralbl Chir (2001) 0.85

Therapy of Caroli's disease by orthotopic liver transplantation. Transplant Proc (2002) 0.85

Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines. Eur Surg Res (2004) 0.85

Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc (2008) 0.85

Changes in serum levels of growth factors in healthy individuals after living related liver donation. Transplant Proc (2005) 0.85

Improvements in staging of gastric carcinoma from using the new edition of TNM classification. Eur J Surg Oncol (1998) 0.85

Split liver and living donation liver transplantation: the Berlin experience. Transplant Proc (2001) 0.85

Hepatic artery thrombosis after orthotopic liver transplantation. Transplant Proc (2001) 0.85

Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Anticancer Res (1997) 0.85

Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs. Transplant Proc (2002) 0.84

Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP). Ann Oncol (2013) 0.84

Upregulation of intraepithelial lymphocyte (IEL) function in the small intestinal mucosa in sepsis. Shock (2001) 0.84

[Spontaneous rupture of hepatic focal nodular hyperplasia--a rare cause of acute intraabdominal bleedingf]. Zentralbl Chir (2002) 0.84

[Living donor liver transplantation of the right liver lobe between adults]. Dtsch Med Wochenschr (2002) 0.83

Increased heterogeneity of coronary perfusion in patients with early coronary atherosclerosis. Am Heart J (2001) 0.83

Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell lines. Anticancer Res (1997) 0.83

Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. Hum Gene Ther (2001) 0.83

Caval complications after orthotopic liver transplantation. Transplant Proc (2000) 0.83

[Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis]. Chirurg (1995) 0.82

Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations. Clin Cancer Res (1997) 0.82

Aneurysms of the hepatic artery after liver transplantation. Transplant Proc (2000) 0.82

Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol (2014) 0.82

Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1. Transplant Proc (2007) 0.82

Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc (2001) 0.82

Treatment of endometriosis of uterosacral ligament and rectum through the vagina: description of a modified technique. Hum Reprod (2009) 0.82

Indication, technique, and outcome of portal vein arterialization in orthotopic liver transplantation. Transplant Proc (2001) 0.81

[Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis]. Verh Dtsch Ges Pathol (1996) 0.81

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast. Br J Cancer (1999) 0.81

Venous coupler for free-flap anastomosis. Anticancer Res (2009) 0.81